Recombinant human granulocyte-macrophage colony stimulating factor (rhGM-CSF) administration after autologous bone marrow transplantation for acute myeloblastic leukemia enhances activated killer cell function and may diminish leukemic relapse
(Q72047974)
scientific article published on 01 May 1995
scientific article published on 01 May 1995
Language: